Three pharmaceutical companies recently formed a partnership to support the discovery and development of next-generation cancer immunotherapies.
For more coronavirus updates, visit...
The FDA recently issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, which have been deemed as two of the most promising COVID-19 drugs.
For...
Bristol Myers Squibb and Exelixis Inc recently announced that CheckMate- 9ER, a pivotal Phase 3 clinical trial evaluating two drugs, showed positive results against untreated kidney cancer...
Researchers recently found no evidence that the use of hydroxychloroquine, with or without azithromycin, reduced the risk of mechanical ventilation in patients hospitalized with coronavirus, according...
Biogen, the Broad Institute of MIT and Harvard, and Partners HealthCare recently launched a consortium that will build and share a COVID-19 biobank, according to a press release.
For more coronavirus...
Roche recently announced the development of a serology test to detect antibodies in individuals who have been exposed to COVID-19.
For more coronavirus updates, visit our resource page,...
The National Institutes of Health (NIH) and Foundation for the NIH recently announced it is joining forces with more than a dozen biopharmaceutical companies to boost COVID-19 drug...
A recent study found that 68 percent of COVID-19 patients who received compassionate-use remdesivir showed clinical improvement, but measurements of efficacy will require ongoing controlled trials to...
A clinical trial to evaluate the safety and efficacy of hydroxychloroquine for the treatment of hospitalized adult COVID-19 patients has begun, according to a recent press release from the National...
The Pfizer Foundation recently announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic.
For more...
The US currently has the most coronavirus cases of any country, with more than 330,000 individuals diagnosed with the virus, according to the CDC . Those are just the known cases, but experts...
As the number of confirmed COVID-19 cases continues to grow, pharmaceutical companies are boosting their efforts to combat the virus. There are currently over 245,000 cases of coronavirus in the US, a...
CVS Caremark, the pharmacy benefit manager business of CVS Health, recently announced that it is working with clients to implement new measures to protect and strengthen the COVID-19 supply chain,...
Genome-sequencing software NVIDIA announced that it will provide a free 90-day license to Parabricks to any researcher worldwide for rapid COVID-19 sequencing, according to a recent press...
The Department of Health and Human Services (HHS) recently announced support for a Phase 2/3 clinical trial to evaluate a possible COVID-19 treatment for severely ill patients.
For more coronavirus...
Hospitalized adult patients with confirmed COVID-19, experienced no benefits in lopinavir- ritonavir treatment compared to standard care, according to a recent clinical trial, LOTUS China...
Earlier this week, Roche announced that the FDA approved its CINtec PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the...
Global specialist HIV company ViiV Healthcare, owned by GSK, and UNC-Chapel Hill recently announced a five-year, $20 million renewal of a public-private partnership to discover a possible HIV...
The Bill and Melinda Gates Foundation, Wellcome, and Mastercard recently launched an initiative to boost drug discovery and biologics to treat patients with COVID-19.
For more coronavirus updates,...
Remdesivir is effective in treating Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), but also may be a successful drug for patients with coronavirus, or COVID-19,...
